Sign in
Join
Discovery/Preclinical
In vitro
In vivo
Newer Targets
Clinical
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Commercial
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
Search
Sign in / Join
Contact
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Discovery/Preclinical
All
In vitro
In vivo
Newer Targets
Clinical
NovaBay Pharmaceuticals to Hold Third Quarter 2020 Conference Call on November…
Clinical
OliX Pharmaceuticals Announces FDA Clearance of the IND to Evaluate the…
Commercial
BioSpace Movers & Shakers, Oct. 30
Commercial
Q32 Stays Busy with $60 Million Series B and First Dose…
Clinical
All
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Clinical
Iovance Biotherapeutics to Host Third Quarter 2020 Financial Results Conference Call…
Clinical
Pharma Industry News and Analysis – FirstWord Pharma – Benefits
Clinical
Pharma Industry News and Analysis – FirstWord Pharma – Benefits
Clinical
Pharma Industry News and Analysis – FirstWord Pharma – Benefits
Commercial
All
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Commercial
Clearside Biomedical to Report Third Quarter 2020 Financial Results and Provide…
Commercial
Oyster Point Pharma to Report Third Quarter 2020 Financial Results on…
Clinical
Iovance Biotherapeutics to Host Third Quarter 2020 Financial Results Conference Call…
Clinical
Trevena, Inc. Announces DEA Scheduling of OLINVYK (oliceridine) injection – FirstWord…
Home
Clinical
Phase II
Phase II
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Phase II
High-Dose Quadrivalent Influenza Vaccine Shows Favourable Phase 2 Trial Results in Children: Presented at ESPID – FirstWord Pharma
Firstwordpharma News
-
October 31, 2020
Phase II
Idera Pharmaceuticals Reports Third Quarter Financial Results and Provides Corporate Update Nasdaq:IDRA
Phase II
Brazil governor says health regulator will not be pressured over coronavirus vaccine – FirstWord Pharma
Phase II
BerGenBio Virtual R&D Day – 06 November 2020
Phase II
BioSpace Global Roundup, Oct. 22
Phase II
RIBOMIC Announces Dosing of First Subject in RBM-007 Phase 1 Clinical...
Biospace News
-
July 15, 2020
0
Phase II
Tiziana Life Sciences plc Change to ADS Ratio
Biospace News
-
July 15, 2020
0
Phase II
IMV Updates Rapid Progress on COVID-19 Vaccine Program
Biospace News
-
July 14, 2020
0
Phase II
CS02 Changes the Landscape of Diabetes Treatment: CenterLab Announces Positive Topline...
Firstwordpharma News
-
July 12, 2020
0
Phase II
EU Approval Of Mesenchymal Stromal Cell Therapy Manufacturing Protocol Using nLiven...
Firstwordpharma News
-
July 12, 2020
0
1
2
3
...
33
Page 1 of 33
- Advertisement -
MOST POPULAR
Tarsus Pharmaceuticals Raises $60 Million in Series B Financing
January 8, 2020
Novel Gene Therapy Generated New Functional Neurons in Mouse Models of...
March 12, 2020
Eloxx Pharmaceuticals Announces Participation in the HIT-CF Project on Cystic Fibrosis
February 26, 2019
Kineticos Announces New Life Sciences Disruptor Fund That Will Launch and...
February 6, 2020
Load more
HOT NEWS
NDA
SK life science announces FDA acceptance of NDA submission for cenobamate,...
Clinical
Tonix Pharmaceuticals Completes Enrollment in Phase 3 RELIEF Trial of TNX-102...
Deals
BriaCell Announces Clinical Trial Collaboration Agreement with Incyte
Approval
Health Canada has approved TALTZ (ixekizumab) for the Treatment of Active...
